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ABSTRACT
The purpose of this study is to explore ex-prisoners’ perspectives on prison drug
treatment in Ireland. Prison drug treatment has increased across Europe over the last
20 years both in availability and modality. However, the delivery of drug treatment
services in a prison setting is not without its challenges. The prison population is a
multiply disadvantaged group, which experiences a disproportionate level of health
inequality and social exclusion. Substance misuse is prevalent for a high proportion of
prisoners. This research is based on seven semi-structured qualitative interviews with
ex-prisoners who have had experience of prison drug treatment. The perspectives of
ex-prisoners add important information to the sparse amount of literature available on
prison drug treatment, especially from a user-perspective. The research found that
different aspects of prison had a significant impact both on individuals and treatment.
These aspects included the following: drugs in prison; prison environment; attitudes;
and policies. An interesting feature of the study is the participants’ understanding of
the many challenges faced by Irish Prison Service. One important finding is the need
for more regular and up-to-date review of prison drug treatment. Accountability
emerges as the most pressing need for prison drug treatment. While there are
structures in place for complaints to be made, these structures are not fulfilling their
function due to a lack of confidence in them. This leaves prisoners in a position of
even greater vulnerability. In this study, ex-prisoners claim their voice amongst the
voices of other actors in the field such as prison staff, medical staff, and politicians.
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CHAPTER ONE: INTRODUCTION

1.1 Introduction
Prison drug treatment in Irish prisons raises many complex issues. There is a lack of
research on it, with less research from a user-perspective. This research topic will focus
on the perspective that ex-prisoners have of drug treatment in Irish prisons. Exprisoners have had the experience of being in the prison system and the advantage of
being able to reflect back on their experience. The proposed research hopes to uncover
key insights which may help in identifying ways to improve drug treatment in prison,
as well as recognizing what is working well. The research will be an opportunity for
ex-prisoners to share their reflective learning from their experience and contribute to
the discourse on drug treatment in Irish prisons.
1.2 Aim and Objectives
This research is an exploratory study of ex-prisoners experience of drug treatment in
Irish prisons.
The main objective will be to document, analyse, and apply the perspectives of exprisoners concerning drug treatment in prison. Some areas of relevance will include
the nature of drug use in prison; the prisoners’ experience of drug treatment; the effect
that prison has on a person’s drug use; and reflections from a post-prison perspective.
The contribution of ex-prisoners will have an intrinsic value, along with having an
important contribution to make towards the shaping of policy and practice.
The research question is “what are ex-offenders’ perspectives on drug treatment in
prison?”
1.3 Summary
The structure of this dissertation is described in this paragraph. Chapter One outlines
the Aims, Objectives and the research question. Chapter Two considers the relevant
literature. Chapter Three describes the methodology of the current study. Chapter
Four outlines the findings of the research. Chapter Five discusses the implications of
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these findings. Finally, Chapter Six provides the conclusion and recommendations
from this study.
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CHAPTER TWO: LITERATURE REVIEW

2.1 Introduction
This chapter is divided into four sections. The first section considers the literature
relevant to prison drug treatment in Europe, under the headings of participant profiles,
the prison environment, delivery of prison drug treatment, and the types of prison drug
treatment. The second section looks at prison drug treatment as a health strategy,
taking into account health needs, human rights, equivalence of care, and duty of care.
The third section examines prison drug treatment and its delivery in Ireland by looking
at recent developments, from 1996 to present day. The fourth section highlights some
specific challenges for prison drug treatment in Ireland.
2.2 Prison Drug Treatment in Europe
2.2.1 European context
Prison drug treatment is not exclusive to European prisons. There is information
available internationally on prison drug treatment, mainly from Australia, Canada and
the United States (EMCDDA, 2012). However, there is a lack of agreed international
definitions on drug use, which makes discussion and comparisons difficult.

The

reasons for choosing Europe in this study are because of the similar understanding and
approach to prison drug treatment in Europe.

The European context also has

information available on prison drug treatment through entities such as the European
Committee for the Prevention of Torture and Inhuman or Degrading Treatment (CPT),
and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
While there are methodological differences between countries in Europe, regarding
data collection and reporting, there is a greater coherence in Europe with regard to
definitions and approaches to imprisonment.
2.2.2 Drugs in Prison
The European prison population has been estimated at 1.67 million people in 2013
(Aebi et al., 2015), with at least half of that population having a history of substance
misuse (Stöver et al., 2014). According to Walmsley (2013), the European prison
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population continues to increase. In Europe, the prevalence of illicit drug use amongst
the prisoner population is higher than the general population (EMCDDA, 2012). In
their global prison population study, Dolan et al. (2015) found that HIV is higher
amongst the prison population because of an over representation of people who inject
drugs.

McIlwraith et al. (2012) noted an increase in the use of benzodiazepines by

prisoners who inject drugs. Wheatley (2007) explains that it is well established that
there are high levels of drug use in the prisoner population. However, he explains that
it is more difficult to establish the actual level of illicit drug use because of factors such
as mandatory drug testing, which influences consumption patterns.
2.2.3 Efficacy of prison drug treatment
There is an acceptance among some commentators of the need to address substance
misuse, not only in the general population, but also within the criminal justice system.
In an examination of contemporary developments in the Scottish criminal justice
system, Malloch et al. (2013) acknowledge the growth of drug treatment services while
also cautioning against coercive treatment. In a survey of treatment programmes in 27
EU countries, Hamilton et al. (2014) observe a variety of treatment modalities and
acknowledge their importance in addressing addiction issues among offenders. In a
study of Finnish prisons, Obstbaum et al. (2015) recognise that evidence-based practice
for prison drug treatment had become the accepted standard in Finland. However, there
is a lack of empirical evidence on how effective drug treatment is in prison. In a
Scottish study on the impact of opioid substitution treatment on drug-related deaths
after prison, Bird et al. (2015) found that opioid substitution treatment did not reduce
early deaths after release. Stöver and Michels (2010) conducted a survey of studies on
opioid substitution treatment in which they concluded that opioid substitution
treatment was less effective in prison than in the general community.

Though, in a

systematic review and meta-analysis of European prison drug treatment, Koehler et al.
(2014) establish the effectiveness of prison drug treatment in reducing future criminal
activity, particularly through the use of substitution therapy; that paper examined in the
region of 37,000 literature titles from six countries, with 3953 participants.
There is limited research on prison drug treatment in Europe (EMCDDA, 2012).
Carpentier et al. (2012) acknowledge that the researching of drug related issues in
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European prisons is hampered by a lack of available data and varying methodologies.
With even less research employing a user-perspective (Frank et al., 2015; Giertsen et
al., 2015), the need for empirical research is acute.

Liebling and Maruna (2005, p.

13) identify prison addiction issues as an area where future researchers need to focus,
as the lack of research, so far, has resulted in ‘sterility’ in this area.
2.2.4 Profile of Participants in Prison Drug Treatment
In Europe, individuals who take part in prison drug treatment share many similarities
with their peers who engage with community based drug treatment (EMCDDA, 2012).
Most of the information that is available on participants is deduced from qualitative
studies (Vandam, 2009). Participants in prison drug treatment generally come from a
background of disadvantage, which includes unemployment, lack of education, and
unstable living arrangements (EMCDDA, 2012). These difficulties are often further
compounded by childhood experiences of poverty, violence, and abuse (Swogger et al.,
2011).

Liebling et al. (2005, p. 216) describe these aspects as “imported

vulnerabilities” which need to be managed in addition to the vulnerabilities which the
prison environment itself generates.

Bauman describes this concentration of

vulnerable people as ‘prisonization’ where they, as the ‘underclass’, having already
gone through a process of exclusion in society, now experience physical exclusion
through imprisonment (1998, pp. 125-127). Bauman holds that ‘prisonization’ serves
as a distraction from the real causes of insecurity in society (1998, p. 127).
‘Prisonization’ is a distraction because it misappropriates the blame for the causes of
insecurity in society onto vulnerable people, which serves as a justification for their
incarceration.

2.2.5 Prison Environment
The experience of drug treatment in prison is interlinked with the prison environment,
which restricts movement and regulates life (Cohen and Taylor, 1972; Woodall, 2011;
Stöver, 2014). Liebling and Maruna (2005) explain that the prison environment is, not
only to do with the physical structure of walls and gates, but also includes the ‘hidden’
features of the social and affective dimension, which include fear, powerlessness,
violence, and uncertainty. The motivations of an individual who participates in prison
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drug treatment may not always be in line with the treatment goals. Motivations can be
for different reasons such as, to attain privileges within the prison, to deal with
boredom, to avoid violence from other prisoners, or to improve their health
(EMCDDA, 2001; Crewe, 2006; Woodall 2011). Koester et al. (1999) calls this “selfprescribed attempts at harm reduction” (1999, p. 1237). The decision of a person to
begin a drug treatment programme is not an easy choice, whether in a community
setting (Al-Tayyib et al., 2011) or a prison setting (Frank et al., 2015). While there are
many reasons for participating in a programme, one dominant theme is the desire “to
get a drug free and normal life after prison” (Frank et al., 2015, p. 159).
Prison is an environment in which some people stop using drugs, others begin using for
the first time, while others change to a different substance because of availability
(Vandam, 2009; Montanari et al., 2014). The reasons why prisoners use drugs in
prison are diverse and include motives such as self-medication, as a coping
mechanism, or as a distraction from routine (Boys et al., 2002; Crewe, 2006; Ritter et
al., 2013; Baltieri, 2014). Prisoners who use drugs are in need of specific support
because of their vulnerability, which includes poor mental health, a risk of overdose,
and disadvantage coming from childhood experiences (Kothari et al., 2002; Swogger et
al., 2011; Herbert et al., 2012).
Drug treatment programmes have a higher chance of success if they are relevant to the
needs of the prisoner, take place over an appropriate period of time, and have the
necessary “through-care” (Ramsay, 2003). If a prisoner can be open about themselves
through drug treatment, in relation to their drug use and personal history, there is a
greater chance of them changing and developing into taking greater responsibility for
their life (Kolind et al., 2013).

However, it can be difficult within a prison

environment for prisoners to achieve this level of openness because of the risk
involved in being vulnerable and the possibility of disclosing unreported criminal
offences (Frank et al., 2015).
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2.2.6 Delivery of Prison Drug Treatment
In an evaluation of prison drug treatment from a user-perspective in Denmark, Kolind
(2007) found that the manner in which drug treatment in prisons is delivered can be as
important a factor as the content of the drug treatment programme itself.
evaluation included 37 semi-structured qualitative interviews with users.

That
Those

interviewed emphasised the importance of easy access to treatment, staff attitudes, and
the availability of spaces. Similar studies from a user-perspective found that easy
access to treatment was important and so too was the attitude of staff (Neale, 1998;
Notley et al., 2012). Liebling et al. (2005) note how the manner in which a person is
treated in prison has a strong influence on perceptions of fairness and can strengthen or
undermine the legitimacy of a prison.
Prison drug treatment in European prisons is generally carried out by prison staff.
However, there is also input from community based groups and non-prison staff who
have a relevant contribution to make. The delivery of prison drug treatment can raise
conflicts of loyalty between staff and prison authorities. This can occur when the need
for appropriate service delivery conflicts with the demands of the prison management
for security and discipline (Pont et al., 2012; Elger et al., 2015). It is an ethical
dilemma which indicates the complex nature of the role of staff involved in prison drug
treatment (Council of Europe, 2006).

2.2.7 Types of Prison Drug Treatment in Europe
Drug treatment in European prisons varies from country to country.

There is a

spectrum of prison drug treatment. The services which are available across Europe
vary in type and application. The services are detoxification, opioid substitution,
counselling, educational and information programmes, and abstinence based
programmes (EMCDDA, 2012). For many countries in Europe, detoxification is used
as the standard response to opiate users and it varies in how it is prescribed in each
country; for example, in Ireland, medical detoxification is available in all prisons,
while in Turkey what is offered is information on drug addiction, on how to manage
withdrawals, and on relaxation techniques (EMCDDA, 2012).
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There is no one standard of prison drug treatment throughout Europe. Ireland provides
both low and high threshold treatment. There are three broad approaches, as explained
by EMCDDA (2012, p. 20).

•

Low intensity drug treatment, which is short-term and includes counselling.

•

Medium or high intensity drug-free treatment in prison within a drug-free
setting.

•

Medium or long term opioid substitution treatment, with methadone or
buprenorphine.

Prison drug treatment aims to improve the health of participants and to reduce the use
of illicit drug use in prisons. By investing in drug treatment in prison, there is a wider
benefit for society such as crime reduction, an increase in public safety, and improved
public health (Redondo et al., 1999; Kothari et al., 2002; Godfrey et al., 2004).

2.3 Prison Drug Treatment as a Health Strategy
2.3.1 Acute Health Needs
The Ottawa Charter (1986) acknowledges the impact that environmental influences or
‘settings’ have on the overall health of a person. This has led to prison being
recognised as a ‘setting’ where health can be influenced (Woodall, 2011). In any case,
prison gathers a specific population of people, who often have a poor relationship with
health services outside of prison (Møller et al., 2007). Health needs of prisoners are
more acute than the general population (Bridle et al., 2004; Barry et al., 2010), as
indicated by the spread of diseases within prison such as Hepatitis C (Allwright et al.,
2000), tuberculosis (Dara et al., 2015) and HIV (Stoever, 2002). This situation makes
prison an important location for health promotion (MacNamara et al., 2014) and also
for the implementation of drug treatment services (Long et al., 2004). However,
Woodall (2011) point out that the prison environment is not only problematic for the
implementation of the principles of health promotion, but that the prison environment
undermines the key values of health promotion, which include participation,
empowerment, and choice. While Garland has described prison as a ‘quarantine zone’,
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it is more for reasons of control rather than public health, where individuals who are
seen as dangerous are isolated for the safety of the public (2001, p. 178). Garland has
noted how prisons have become “a faute de mieux repository” for people with
problems such as mental ill-health and substance misuse issues, among other things
(2001, p. 178).
2.3.2 Fundamental Human Rights
Every human being has the fundamental right to the highest attainable standard of
health.

This right is articulated in Article 12 of the International Covenant on

Economic, Social and Cultural Rights (United Nations, 1966). This right to health is
shaped in practice by what is possible for the State to provide and, also, how, if at all,
an individual engages that right (United Nations CESCR, 2000: No. 14).

This

fundamental right holds for prisoners as it does for the general population. The United
Nations (1990) Basic Principles for the Treatment of Prisoners is clear that prisoners
hold onto this right to health regardless of their imprisonment (Principle 9). The
Council of Europe (2006) articulated that prisoners hold their human rights with the
limitation of that which is lawfully restricted because of the requirements of
incarceration.
2.3.3 Equivalence of Care
The principle of “equivalence of care” requires that people have access to a level of
care that is equivalent to what is available to the general public in the same country
(Niveau, 2007, p. 610). The principle of ‘equivalence of care’, as it relates to prison, is
recognized on an international level in the United Nations Basic Principles for the
Treatment of Prisoners (1990), the World Health Organisation (WHO) (Møller et al.,
2007), and in the European and International Prison Rules. In Europe, the Council of
Europe has recognized ‘equivalence of care’ as a basic principle for the care of
prisoners (1993; 1998).
The principle of ‘equivalence of care’, when applied to prison, is a strong indicator of
how society practices the principle of equality for all of its citizens (Niveau, 2007, p.
610). Equivalence is achieved when drug treatment services that are available in the
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wider community are also available and accessible to the same degree within the prison
setting. However, it is acknowledged by WHO (Møller et al., 2014, p. 116) that
equivalence of care in relation to drug treatment is not the case for many European
prisons. This indicates a growing recognition of the need to reduce the gap between
prison healthcare and community healthcare (EMCDDA, 2012).
2.3.4 Duty of Care
The ‘duty of care’ owed by the State to a prisoner requires that, not only is health care
available, but that there are appropriate structures to promote well-being amongst
prisoners and staff (CPT, 1998). The Council of Europe (1993) and the European
Court of Human Rights (McGlinchey Case, 1999) have affirmed the ethical and
organizational obligations of the State to care for the health of prisoners.

The

interpretation by the European Court of Human Rights of Article 3 of the European
Convention on Human Rights (ECHR) established the special duties of authorities, not
just towards prisoners with physical or mental disabilities, but also for prisoners with
drug problems (Herrick, 2009).
While prisons are not the appropriate place for drug treatment, in the absence of an
alternative, prisons need to respond to prisoners requiring drug treatment and do so in a
way which respects minimum standards (Stöver et al., 2014).

2.4 Prison Drug Treatment in Ireland
2.4.1 Drug use in Irish prisons
The prison population in Ireland is a complex group of people who experience more
acute levels of health inequality and social exclusion when compared to the general
population (Barry et al., 2010; MacNamara et al., 2014). Drug use is a serious issue
amongst prisoners in Ireland (Drummond et al., 2014). The Council of Europe noted
that drug misuse (CPT, 2010) and drug availability (CPT, 2011) remain serious issues
for Irish prisons and prison drug treatment. The lack of monitoring and oversight of
prisoners in withdrawal and whether or not they were continuing to use illicit drugs
while on methadone maintenance was also mentioned by the Council of Europe (CPT,
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2011, p. 42). Appropriate support and in-cell sanitation for prisoners undergoing
withdrawal was emphasised as a basic necessity (CPT, 2011).
Reports from the Inspector of Prisons (Limerick, 2011) and the Mountjoy Prison
Visiting Committee Report (2012) also highlighted the drugs issue in prisons and
indicated that most prisoners have addiction problems and that some people become
addicted while in prison. The suffering of prisoners has been documented in Inspector
of Prisons Reports as “inhumane and degrading treatment” (2010, paragraphs 9.2, 11.9
and 14.8). Cohen’s “states of mind” perhaps indicates a state of denial in Ireland as to
some aspects of prisoner care where a “knowing and yet not knowing” state of denial
exists (Cohen, 2001). However, the tolerance of illicit drugs in prisons may reflect an
unstated containment strategy of prison staff so as to help prisoners cope with their
environment and avoid escalation in prisoner violence. The tolerance of illicit drugs in
prisons could also reflect a compassionate approach to dealing with prisoners. The
supply of drugs into prisons would be significantly reduced if contact visits were
prohibited. However, while reducing the amount of drugs in prisons, denying prisoners
contact visits would also create significant distress for them and their families.
2.4.2 A Need for Research
The Irish Prison Service has been described as “a significant provider of drug addiction
treatment” because of the high number of prisoners who have a substance misuse
problem (NACD, 2006, p. xv; Comptroller and Auditor General, 2009, p. 68).
Compared to the available research on drug use in Irish prisons (Allwright et al., 1999,
2000; Long et al., 2004; Dillon, 2001; Moore et al., 2007), Drummond et al. (2014)
point out that there is very little on prison drug treatment in Ireland and even less from
a user-perspective.
One criticism of the Report of the Steering Group on Prison Based Drug Treatment
(2000) is that prisoners were not consulted in the process (Long et al., 2004). This
shortcoming was remedied through the involvement of prisoners in the National
Advisory Committee on Drugs and Alcohol Report (Drummond et al., 2014), which
was part funded by the Irish Prison Service, with publication including a prisonerfriendly Report.
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The growth in prison drug treatment in Ireland over the last twenty years has not been
reciprocated with a growth in research. While there is much research available on
community based drug treatment, Drummond et al., (2014) acknowledge that there
remains a deficit of research regarding prison drug treatment in Ireland.
2.4.3 A Recent History of Prison Drug Treatment in Ireland
Co-ordinated drug treatment in Irish prisons is a recent development beginning with
the introduction of detoxification and addiction counselling in 1996. This was a
response to the growing needs of prisoners in this area. In 1999, the draft Action Plan
on Drug Misuse and Drug Treatment in Irish Prisons was published. This was a
general strategy to develop prison drug treatment. It included expanding detoxification
facilities and drug-free environments, providing methadone maintenance and hepatitis
B vaccination, and providing addiction counselling and employment of registered
nurses.
This was followed by the Report of the Steering Group on Prison Based Drug
Treatment Services (2000) which sought to implement the Action Plan. It outlined a
drug treatment service to be centralised in Mountjoy prison, which sought a multiagency approach and it recognized the principle of ‘equivalence of care’ which was
seen as “one of the most significant conclusions of the Report” (O’Mahony, 2002, p.
584).
A dominant theme of the Report is ‘through-care’ which seeks to develop and sustain
continuity between the prisoner and community (O’Mahony, 2002). However, it has
been criticized for not detailing what ‘through-care’ and ‘equivalence of care’ with the
community would mean in practice (O’Mahony, 2002).
The Drugs Policy and Strategy of the Irish Prison Service was published in 2006 and is
the main document of reference for prison drug treatment in Ireland. It points out the
tensions that exist with the ‘twin challenges’ of security and the needs of the individual
(2006, p. 2). It also acknowledges the reality of drugs in prisons and the wider effects
that this can have, which include bullying, intimidation and violence. However, the
Policy and Strategy sets out a zero tolerance to the presence of drugs, which is to be
achieved through the elimination of supply, which the Inspector of Prisons has
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described as “an ambitious aspiration” (2009, p. 37). The Annual Report (2014) of the
Irish Prison Service states that targeted cell searches including five targeted operations
were carried out by the Operational Support Group. These searches resulted in a large
haul of contraband being seized. The Report also states that four canine instructors
were trained and are now available to deliver training to Irish Prison Service canine
teams.
The Policy and Strategy aims to reduce demand for drugs in prison. It states that
demand will be reduced in three ways (i) identify and engage with drug users, (ii)
develop treatment options, and (iii) ensure that ‘throughcare’ takes place so as to
support the treatment links between the prison and the prisoner’s community to which
he or she will return to (2006, p. 13). ‘Throughcare’ is of particular importance to Irish
(Lyons et al., 2010) and international (Strang, 2015) research which shows a
significant risk of death upon release for drug using ex-prisoners.

2.4.4 Delivery of Prison Drug Treatment in Ireland
There are 14 prisons in the State. The average daily population at the time of writing is
around 3,650 prisoners (Irish Prison Service Website). Drug treatment varies between
prisons, with both low and high threshold drug treatments. The Irish Prison Service
has a Drug Treatment Clinical Policy (2008), the aim of which is to provide a high
standard of care to prisoners with addiction issues. The Clinical Drug Treatment Policy
gives evidence-based reasons for its recommendations. The recommendations are
comprehensive and cover aspects of care such as methadone treatment guidelines, a
confidentiality policy, detoxification guidelines, and much more. The most recent
Annual Report (2014) of the Irish Prison Service indicates further development and
enhancement of drug services.

It also commits to reviewing the Clinical Drug

Treatment Policy. The Annual Report also noted the ongoing development of drug
free units in all closed prisons.
Central to the delivery of drug treatment services is courtesy and respect for everyone
involved. In the recent Strategic Review of Penal Policy (2014), it was acknowledged
that drug treatment does not work without an individual’s willingness to co-operate.
However, the Mountjoy Visiting Committee suggested registering all prisoners
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affected by drug addiction in drug treatment programmes (2012). This suggestion,
which has a coercive element to it, would need careful consideration. According to
Seddon (2007) and Ryberg (2013), particular attention is needed to address the ethical,
legal and moral difficulties raised by coercive drug treatment in prison.
Prison drug treatment in Ireland includes addiction counselling, methadone
maintenance, medical detoxification, rehabilitation, information, and education
programmes (Irish Prison Service Website). Individual assessment is seen as key to
good service delivery (Clinical Drug Treatment Policy, 2008, p. 6).

While there are

questions as to the effectiveness of methadone maintenance, the Drug Treatment
Clinical Policy accepts it to be more effective than having no treatment at all (2008, p.
9). While it should also involve psychosocial care (Stöver et al., 2014), on a recent
visit from the Council of Europe, it was found that psychosocial support in this area
was lacking in Irish prisons (CPT, 2011). Detoxification has been described by the
Council of Europe (2002) as a gateway to treatment meaning that on its own,
detoxification does very little to counteract long-term drug use (Clinical Drug
Treatment Policy, 2008, p. 9, 22). However, after completing detoxification,
individuals are required to receive other supports to ensure that their low tolerance
does not lead to an overdose (Clausen, 2015).
Mandatory testing for drugs was introduced by the Irish Prison Service Drugs Policy
and Strategy in 2006. It makes provision for the random selection and testing for drugs
of between 5% to 10% of prisoners each month. Sanctions are imposed if a prisoner
tests positive for drugs or refuses to be tested. Mandatory testing seeks to reduce
demand for drugs in prison by engaging with drug-users so as to involve them in drug
treatment services. Claims that mandatory drug testing encourages prisoners to switch
from cannabis to heroin, because heroin exits the body quicker, have not been
substantiated in research (Hucklesby et al., 2001).

Between 1999 and 2010, the Irish Prison Service has put over €8 million into
healthcare services (Ailbhe Jordan, Medical Independent 10th June 2010). According
to the Annual Report (2014), the budget for the Irish Prison Service is €334.188
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million. This is slightly down on the budget for 2011 which was €347.583. There was
no figure available for spending on prison drug treatment in the 2014 Annual Report.
Therefore, it is not possible in this study to make comparisons with other expenditure
in the Irish Prison Service. Most recently, the Irish Prison Service has introduced the
Prisons Pilot Project Helpline which began in December 22nd, 2014. It is a Helpline
from which prisoners can discuss issues including drugs and alcohol, with no time
limit, and in confidence. It is an innovative approach to supporting prisoners. As the
Prisons Pilot Project Helpline will be reviewed in 2015, there could be relevant
information available to guide the Irish Prison Service, taking into consideration the
confidentiality of the service.
The challenges for prison drug treatment in Ireland are multifaceted and complex.
However, this also presents an opportunity for positive intervention through drug
treatment programmes (Moore et al., 2004) particularly when a prisoner wishes to
address drug misuse (Long et al., 2004).

2.5 Some Challenges for Prison Drug Treatment in Ireland
2.5.1 Need for Accountability and Review
Coyle notes the consequence of treating the prisoner as an object rather than a person
(Liebling and Maruna, 2005). In such cases, the role of the prisoner is to simply cooperate with decisions made by others without being involved in the decision
themselves. However, accountability requires that those who make decisions about
others are also answerable for those decisions (Cavadino and Dignan, 2007, p. 230).
Rogan (2014, p. 3) comments that “perhaps the most fundamental difficulty in the Irish
prison system concerns the weakness of structure for ensuring accountability for
decisions taken by the prison authorities or responding to matters of concern.” It is
evident from the development of prison drug treatment in Ireland that prison conditions
have improved. However, there are issues of concern within prison drug treatment that
would benefit from a strong, independent system of oversight.
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Cavadino and Dignan (2007, p. 230) note that a number of agencies concerned with
prisons can elicit “a degree of answerability” for the decisions made in prisons. The
office of the Inspector of Prisons has been an important development in the area of
accountability, by highlighting shortcomings related to prison drug treatment. Other
forms of accountability include legislation, Annual Reports, Visiting Committee
Reports, International Committees Reports and independent oversight such as from the
Irish Penal Reform Trust. However, the prison, as a closed environment, makes it
more difficult to establish accountability (Harding, 2007).
A review of drug treatment in prison was recommended by Mountjoy Visiting
Committee (2012). On 18th May 2015, at the launch of the Joint Probation ServiceIrish Prison Service Strategy 2015-2017, the Minister for Justice acknowledged the
importance of improved addiction services for offenders.

The Minister then

announced that a Review of Drugs and Alcohol Services to Offenders would begin in
the near future. There are no more details available on this Review.

2.5.2 Unreliable Access
While there is a high uptake of drug treatment in Irish prisons, within the range of 7090% of those interviewed by Drummond (2014), access to treatment is not always
available (Drummond et al., 2014, p. 88). The high level of engagement by prisoners
is seen as a strong indicator that the prison setting is an appropriate place for drug
treatment (Drummond, 2014). However, the difficulty with access to treatment leads to
frustration amongst prison staff and prisoners (O’Gráda, 2010). The Inspector of
Prisons in Ireland highlighted the impact that 23 hour lockdown has on limiting the
access to drug treatment for that prisoner category (2013, p. 13). It also undermines
the prison drug treatment system by inhibiting access to treatment.

The access

difficulty appears to be a continuing issue, as it was raised recently as a concern by the
Strategic Review of Penal Policy (2014). Other challenges which interfere with full
access to treatment include the prison regime, staff attitudes, and the relationship
between staff and prisoners (McIntosh & Saville, 2006).
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2.5.3 Effectiveness of prison drug treatment
The 2006 Policy and Strategy acknowledges the importance of having good quality
research to underpin its approach (2006). It acknowledges the need for more research
into prison drug-related issues. In the context of the Policy and Strategy, there is
meant to be research on drug misuse in prisons, an evaluation of programmes and
interventions and a sharing of research data. The Policy and Strategy also aims to
evaluate the effectiveness of drug interventions.
The effectiveness of prison drug treatment will be very difficult to evaluate without
sufficient research. Research is important to influence the decision-making of policy
makers and service providers. This research needs to be kept up-to-date and done
regularly and not just focused on the elimination of drug use. Recent international
research (Hamilton et al., 2014) pointed out shortcomings between routine practice and
international research, which indicates the need to ensure that evaluation of routine
practice is a regular occurrence. Liebling and Maruna (2005, p. 2) note that shortage
of research on the modern prison has generated “an ethical and intellectual void” in
which the result has been the undermining of the quality and legitimacy of prisons.

2.6 Ireland in the context
Comparisons between Ireland and other European countries are made difficult because
of the variations throughout Europe in data collection and methodologies. While there
is consensus in most European countries of the need for a developed prison drug
treatment service, a European classification system would assist in the collection of
relevant data and assist in the development of current, evidence-based information.
Opioid substitution is one of the main treatments in most European countries.
Comparisons are difficult to make because of the absence of reliable data as to the
number of prisoners using this treatment.

With regard to the long-term care of

prisoners, compared to Greece, Cyprus, Lithuania and Slovakia, where long-term
opioid substitution is not prescribed, Ireland compares favourably by providing longterm opioid substation.
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While there is interagency work between the Irish Prison Service and health care
providers for the delivery of prison drug treatment in Ireland, there is a trend in Spain,
France, Italy, Slovenia, Sweden, United Kingdom and Norway to transfer
responsibility for the delivery of health care, which includes prison drug treatment, to
the same structure which provides healthcare in the community (EMCDDA, 2012).
This shift affects 40% of the European prison population. It is a response to the need
for integration of prison health structures with those in the community and to improve
the continuity of care for prisoners.

In Sweden and the United Kingdom, there was

also increased funding to encourage prisoners to engage with drug treatment
(EMCDDA, 2012). Given that Spain, Scotland, and Italy are considered as operating
within best practice for both harm reduction and treatment services, and are also part of
this trend of integration, it is an opportune time to consider how Ireland may respond
to this trend.

2.7 Conclusion
A constant refrain throughout this literature review has been the lack of empirical
research in general on prison drug treatment and in particular from a user-perspective.
This chapter has considered prison drug treatment, in general, in both a European and
Irish context, with a particular focus on the service user. While there are many
standards and legal requirements in place and many issues needing attention, what
arises from this chapter is the need for robust structures for accountability and regular,
up-to-date research. While the perspective of ex-prisoners is not the final word on
prison drug treatment, it does contribute an authoritative narrative which has a solid
contribution to make towards the design, delivery and administering of an ethically
sound prison drug treatment service.
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CHAPTER THREE: METHODOLOGY

3.1 Introduction
This chapter identifies and discusses the methodological framework employed in this
study. It contains an overview of the research rationale, strategy, design and approach.
It outlines the relevant information regarding participants. The data collection and
analysis is discussed. Finally, the ethical issues and limitations of the research are
considered.
3.2 Overview of the Research Rationale, Strategy, Design and Approach
The aim of this research is an exploratory study of ex-prisoners perspectives of drug
treatment in Irish prisons. It does not purport to be a comprehensive examination. The
research question is “what are ex-prisoners perspectives on drug treatment in prison?”
The main objective will be to document the perspectives of ex-prisoners concerning
drug treatment in prison. Some areas of investigation will include the nature of drug
use and drug treatment in prison; the prison environment; the prisoner’s experience of
drug treatment; the effect that prison has on a person’s drug use; and reflections from a
post-prison perspective. The contribution of ex-prisoners will have an intrinsic value,
along with having an important contribution to make towards the shaping of policy and
practice.
The research design is phenomenological and the research has a qualitative approach.
This allows for the insights of those interviewed to be expressed through understanding
the subjective experience of the ex-prisoner of drug treatment in prison (Gelo et al.,
2008; Foddy, 1993). As there is little research available on drug treatment in Irish
prisons, an exploratory study will shape the qualitative strategy (Stebbins, 2001, p. 6).
With this gap in research, the qualitative research approach needs to be of a depth and
quality to offer a substantial body of knowledge.

A qualitative approach uncovers

attitudes, perceptions and understandings and looks into the meaning of what is
presented (Burnett, 2009).

This is distinct from a quantitative approach which

measures and weighs information from a more objective disposition. The qualitative
approach compliments the phenomenological research strategy which acknowledges
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the knowledge and understanding contained within the lived experience of participants
(Creswell, 2011). The qualitative approach and phenomenological strategy will help
uncover how people make sense of their lives in their own words and, so, enable an
understanding of the context of drug treatment in prison (Lincoln et al., 2003, p. 603).
The importance of the subjective view of ex-prisoners in this research is an
‘interpretivisit’ epistemology.

This means that the topic is viewed through the

perspective of the participant (Bryman, 2012). To compliment this, the research uses a
‘constructionist’ ontology which understands the world as “constructed in and through
interaction” rather than through external definitions (Bryman, 2012, p. 34). This will
be of particular relevance when noting the official reasons given for why people
engage with prison drug treatment compared to the reasons given by individuals
themselves as to why they engage with prison drug treatment.

3.3 Research participants
At its core, this research seeks to understand drug treatment in Irish prisons from the
perspective of the ex-prisoner and to understand the lived experienced and meaning of
daily life. It is an exploratory study which uses a convenient sample and scopes out
areas for further research.

Therefore, the sample selected is not a representative

sample. There were four criteria for inclusion of participants. These were to be an exprisoner, who had used drugs and/or alcohol, who was over eighteen years of age, and
had some experience of prison drug treatment. Though initially the researcher set out
to talk with anyone within that criteria, it was only men who presented for interview.
In addition to the inclusion criteria, participants for this research, had to have spent at
least one month in prison, either on remand or under sentence. The periods in prison
of participants who were interviewed ranges from nine months to 12 years. The
participants had used alcohol and a range of drugs including heroin, cannabis,
amphetamines and cocaine.
There are difficulties in accessing ex-prisoners for different reasons. These include
issues of bias, trust, and labelling. In light of these obstacles, and the need to progress
the research, non-probable purposive sampling was used (Denscombe, 2010a). This
meant that the selection of participants was influenced by those who were available
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and willing to participate and who fulfilled the criteria (Rubin and Rubin, 2005). As
the sample selection was not representative of the group, the fact that it is small in
number does not interfere with the research objectives. The researcher considered
using focus groups but decided against it because of the possibility of people being
uncomfortable to speak freely within a group. The main advantage in using focus
groups would have been expediency. The researcher found that individual interviews,
with the sample selection of 7 participants, was time-consuming.
Reflexivity is an important consideration for the role of the researcher.

It

acknowledges that there is a relationship between the researcher and the social world
being studied (Punch, 2005).

Reflexivity means that a researcher cannot attain a

purely objective standpoint outside of the social world but uses their perspective of the
world to make sense of it.
3.4 Data Collection and Procedures involved
A qualitative research approach was used to collect data. This was carried out through
interviews with participants which assisted in unpacking the complexity of drug
treatment in prison (Creswell, 2009). The method of data collection was structured
through the in-depth interviews of seven adult males. This approach helped establish a
deeper understanding and portrayal of the perspectives of people who have spent at
least one month in prison and who have had some experience of drug treatment in
prison (Denscombe, 2010; Creswell, 1994). The researcher has particular experience
of working in a prison. Costley et al. (2010) hold that work-based knowledge can be
an advantage because it provides a knowledge and experience gained from that work.
Initial contact was made through the director of five community based organisations
which work with ex-prisoners with the Information Letter (Appendix 2). For unknown
reasons, there was no response from two of the organisations.

Out of the three

organisations who responded, two were available to participate within the given timeframe. Issues of access, gatekeeping, and informed consent were considered. To
receive informed consent from a participant requires a clear and informative
Information Sheet (Sarantakos, 2005). The Information Sheet (Appendix 3) which was
used for this research explained what the research was about and why it was being
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done. It also explained the time commitment required of the participant, which was
one interview for a maximum period of one hour. The interviewee was asked if it was
acceptable to record the conversation. Three participants did not give permission for
the interview to be recorded. In those cases, the research took extensive notes during
the interview and for two hours after each interview. The reasons given for not having
interviews recorded were to do with doubts about confidentiality, the similarity to
being interviewed at a Garda station, and not wanting to get in trouble. The interviewee
was informed before the interview began that he was free to discontinue the interview
at any time.

Confidentiality and its limits were explained and the consent form

(Appendix 1) was signed. After each interview, reference to the person’s name on the
digital recorder was removed and replaced with a number to protect anonymity. Once
the interview was transcribed and verified, the interview was deleted from the digital
recorder.
Participants were not approached directly by the researcher. Instead, an information
letter (Appendix 2) was emailed to the director of each project seeking access to
research participants. The director acted as an initial gatekeeper, deciding whether the
request should be granted and they appointed a staff member to continue the process.
The staff member, appointed as a gatekeeper, facilitated access to the project, helped
locate research participants, and identified a suitable place for the interview to take
place. Compromise and negotiation were part of the process to seek access. This
helped to establish good boundaries and mutual understanding. It was important that
the seven participants had a history of drug and/or alcohol use before or during their
prison experience. The lived experience of those interviewed brought about a better
understanding of the research topic (Creswell, 1994). A qualitative approach helped
draw out the meaning and context of the lives of people interviewed. This gave a solid
foundation on which to investigate and scope out the research topic.

3.4.1 Interviews
All the interviews took place in the Project where the individual was contacted, except
for one which took place in a hotel board-room. The reason for the hotel interview was
because the participant wanted more privacy than what was possible in the Project.
The researcher suggested a hotel board-room and the participant agreed.
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The

researcher paid for the hire of the room. All the interviews had a conversational style
rather than formal. However, it is important to note that, while conversation and
interviews have similarities, there are important differences (Denscombe, 2010b).
Some of these differences are that consent is required from the interviewee and that the
agenda is set by the researcher (Denscombe, 2010b).
The interviews in which a digital recorder was used helped the researcher to focus
more on the participant. It was also very beneficial in transcribing the interview
afterwards. The use of a digital recorder avoided the distraction of note taking and also
helped to know what exactly was said. Some notes were taken during the recorded
interviews to capture body language and other things that a recording would miss out
on.
It was important that the main questions were defined enough so as to have a specific
focus but not so defined that it would pre-determine responses (Rubin and Rubin,
2005). To encourage participants to talk more and to avoid a flood of questions from
the researcher, there were 27 questions in the interview schedule. This was to avoid
rushing through an interview and also to give the participant an opportunity to talk
(Rubin and Rubin, 2005).

The interview schedule was reviewed after the first

interview. This review resulted in some questions being eliminated because they were
‘closed’ questions which inhibited the flow of the interview. Other questions were
eliminated because the researcher felt that they encroached on the interviewee’s
privacy. Other questions were merged into one because of similarities.
The questions for the interview began with general questions about sociodemographics and drug-use history. As the interviews continued, there was more
specific information sought, such as the type of drugs used, frequency of use, and
perceptions of drug treatment in prison (Denscombe, 2010a). Literacy difficulties were
taken into consideration so that the interview language was presented in plain English
and easy to understand. As the interview process was an essential part of the research,
it needed to be organized properly beforehand so that the interviewer was familiar with
the flow of questions.

The interviews were purposeful and controlled by the

interviewer so that it did not stray into irrelevant areas (Kvale, 1996). There was a
struggle at times between the researcher and the interviewee to keep the interview
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focused on prison drug treatment.

This was because when interviewees became

comfortable they were inclined to continually talk.

3.5 Framework for Data Analysis
Data analysis was inductive. The qualitative researcher used the data as the foundation
on which to the apply theory and concepts. The data was thematically analysed
manually. Each interviewee was given a unique number so as to help with easy access
back and forth over the data. It also provided anonymity for the participants. Important
themes and concepts in the transcript were coded and these items became apparent
after familiarity of the transcript was achieved. Every code was linked to each other in
an overall coding structure (Rubin and Rubin, 2005). An integrated approach for
coding was used to include a predetermined set of codes and a set of codes that arose
from the transcript. Some codes were obvious because they were explicitly mentioned
in the text, while other codes were less obvious but were still noted. There were
particular phrases, like motifs, throughout the text, which gave insight. Definitions
were important so as to properly assign themes, concept and issues. Being clear on
definitions and context helped to clarify how items should be coded. By grouping
certain things together, a picture began to emerge of what was being analysed. This
was compared and contrasted with findings from other research so as to come to a
better understanding of the research topic. Coding produced a picture of themes and
contexts which then provided a platform from which to present findings. Themes
should have numerous quotations and perspectives to flesh them out (Creswell, 2009,
p. 189). This helps with the thematic analysis (Bryman, 2012). The repetition of a
topic, however, does not automatically make it a theme. Rather, a theme develops
through reflection.
As the coding was produced, new ideas emerged, requiring a number of reviews and
changes before the final code was decided on. How the researcher shaped the coding
had definite impact on the results of the data analysis. Therefore, it was important to
give sufficient attention to this important process. Coding helped identify similarities
and differences between different codes and also how different people experienced a
particular event (Rubin and Rubin, 2005).
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3.6 Ethical Issues and confidentiality
Ethics is an essential consideration for all social research (Punch, 2005).

It is

important because social research concerns the personal lives of people. This needed
to be handled appropriately, with the added effect of the participants in this research
being a vulnerable group.

Ethics guards and protects the integrity of the research

project (Thorseth, 2003). It also protects the good name of research, enabling future
research to be carried out, so leaving a legacy (King, 2000). In this research, there are
ethical issues raised regarding personal disclosures, access to participants, storing data,
and informed consent (Israel et al., 2006). These ethical issues were navigated under
the ethical guidelines for taught postgraduate research dissertations at DIT.

The

methodology is aligned with these guidelines. Ethical approval was provided by the
Head of School of Languages, Law and Social Science in DIT.
Confidentiality was assured, with the exception of any disclosure which indicated a
danger to the participant or to someone else. Access to participants was through
gatekeepers.

Each Project was furnished with a Letter and Information Sheet

explaining the research. Each participant received a Letter and Information sheet.
Informed consent was sought from participants through the provision of an information
sheet with any necessary explanation. Data from the study was stored securely during
the research and then destroyed when the research was completed.
3.7 Limitations
The present study was subject to a number of limitations. Firstly, the group of
participants is small in number. It will not be possible to make generalisations from
such a small group (Bryman, 2012).

While it is not possible to hold complete

objectivity (Bryman, 2012), the use of an ethical and professional approach to this
research helped to overcome this limitation.

Another limitation is that all of the

participants were men. A gender balance may have had an influence on the results.
With these limitations, the sample is not representative of the whole prison population
nor of users of prison drug treatment.
While the researcher has past experience of working in prison, the work was not
specifically related to prison drug treatment. However, it nonetheless bestows on the

	
  

25	
  

researcher an appreciation of the prison environment. This familiarity is beneficial in
providing a ready-made foundation on which to build on but it may also be a drawback
by placing the researcher too close to the research topic for objectivity. However, the
substantial literature review provides considerable material for a challenging exchange
on any research findings (Denscombe, 2010a).

3.8 Conclusion
This chapter has identified and explained the methodology under which this research
will be carried out. It has also explained why and how qualitative data collection were
used so as to help achieve the aims and objectives of this research. The framework for
data analysis gives the process by which the information will be analysed. The ethical
issues raise awareness about the importance of observing best practise for the
protection of everyone and especially the participant. Finally, the limitations of this
research were mentioned.
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CHAPTER FOUR: FINDINGS
4.1 Introduction
This chapter presents the data which was gathered through the interviewing of seven
participants. The profile of the participants and the selection criteria is outlined. The
data is divided thematically into six themes.

The six themes are the prison

environment, prison drug treatment, communication, change and Policy impact,
attitude and motivation, and, finally, accountability. Each theme is expanded on with
the aid of the narrative from participant interviews.

4.2 Profile of Participants
Seven Irish white male participants were interviewed individually on one occasion for
a period of between 25 minutes and one hour. Each participant fulfilled the selection
criteria for the research. This criteria was that each participant was over 18 years of
age, who had used drugs and/or alcohol and had some experience of Prison Drug
Treatment in Ireland.

The use of an audio-tape was permitted by four of the

participants, with the interviewer taking notes for three other participants. The reasons
for not wanting to be audio-recorded were that they did not want the audio tapes to get
them into trouble; audio-recording reminded participants of Garda interview rooms and
the Boston College IRA Tapes were an example of how research agreements on
confidentiality can be broken.
At the time of interview, four participants were in full-time employment and three
were participating in services which seek to re-integrate ex-prisoners into society. The
first experience of prison for participants was between the ages of 18 and 24. The
overall time span relating to prison ranges from 1995 to 2015. This gives a good timeline with regard to the development of prison drug treatment over a twenty year period.
Interviewees articulate a wide range of perspective on prison drug treatment.
Interviewees are noticeably insightful, reflective, and balanced in their comments.
Being at a stage in life where they can reflect back on their prison experience, their
perspectives are enriched by their age, education, work experience and life experience.
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Participant

Age

Drug-use

Prisons in

periods of time

Level of

Overall

before prison

which time

in prison

education

time span
2002-2006

served
Participant 1
Participant 2

37
35

Alcohol and

Mountjoy and

One period of six

Third level

heroin

Portlaoise

years

Degree

Alcohol and

Cloverhill,

One 3 year

Junior Cert and

heroin

Mountjoy,

period. Multiple

Fetac Adult

Wheatfield

short-term

Education.

and

periods of

Portlaoise.

average 6 months

1998- 2014

duration
Participant 3

Participant 4

32

38

Alcohol, hash,

Cloverhill and

Multiple short-

ecstasy,

Mountjoy

term periods of

cocaine and

average 6 months

heroin.

duration

Junior Cert

2005-2015

1995- 2003

Thinners, hash,

St. Patricks

Multiple short-

Junior Cert and

LSD, speed,

Institution

term periods of 7

FETAC Adult

ecstasy,

and Mountjoy

months

Education.

Alcohol and

Wheatfield,

Long-term

Third level

heroin.

Portlaoise,

sentence

degree,

alcohol
Participant 5

39

Mountjoy

1999-2009

Training
Course in
Addiction

Participant 6

37

Chaotic opiate

Wheatfield

One period of 4

Fetac Adult

user

and Mountjoy

years

Education.

1998-2002

Training
Course in
Addiction
Course
Participant 7

34

Alcohol,

Mountjoy

cannabis,

	
  

One period of 5

Junior Cert and

years.

FETAC Adult

ecstasy,

Education.

cocaine and

Third level

LSD.

Degree
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2006-2011

4.3 The Prison Environment
The first theme presented is the prison environment. It arose as a theme out of a
general question posed to participants of what they found difficult about prison drug
treatment. It was a broad question so as to encourage participants to talk about their
experience of prison drug treatment. As participants responded to the question, they
introduced specific aspects of the prison environment which impacted on their
experience of prison drug treatment. These aspects of the prison environment were
considered as normative. Some aspects were clearly experienced as negative or
positive in their effect. There are five aspects to the prison environment presented
below.

4.3.1 Prison Culture
Prison culture, as it relates to prison drug treatment, arose in all of the interviews.
Prison culture is often marked with a constant threat or perceived threat to personal
safety which can hold individuals in a state of hyper-vigilance.
For one participant, he did not experience prison drug treatment in itself as particularly
difficult. However, the prison environment had an adverse effect on his willingness to
engage fully with prison drug treatment.
“What would be difficult is you are in an environment, a prison environment.
So its quite difficult … to show any vulnerability” (Participant 6, Age 37)
The threat of being attacked in prison meant that there was a constant fear for one’s
personal safety. As a result, individuals developed a suspicion of their surroundings.
Prisoners sought to maintain their full physical strength in case of attack. Therefore,
participating in prison drug treatment was perceived as leaving you in a weaker state
and so more vulnerable to attack.
“Prison is a rough place … if you’ve to watch your back all the time and then
you take treatment, it leaves you weak.” (Participant 2, Age 35)
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This participant believed that the prison setting was not suitable for drug treatment. He
pointed out that drug treatment is not just about ‘getting clean’. It also involves
psycho-social aspects such as a stable environment and absence of threats.
“Prison isn’t the place for that (drug treatment). It’s not just about getting
clean, you need a steady life but in prison you’ve gotta watch your back, you’ve
gotta survive … doing treatment in prison leaves you weak to attack”.
(Participant 3, Age 32)

4.3.2 The Prisoner Code
The 'Prisoner Code’ is a value system amongst prisoners which demands loyalty to
fellow prisoners. It is an unwritten but clearly understood prohibition on reporting or
‘ratting’ to prison authorities. One participant spoke of how an individual in his
therapy group was using drugs. As the ‘prisoner code’ demands strict loyalty to other
prisoners, he felt unable to challenge that individual in front of the therapist and prison
staff.

Therefore, the ‘prisoner code’, which is an inherent part of the prison

environment, had compromised the therapy group.
“No matter how big you are or how tough you are, if you are on a treatment
programme and there’s somebody who’s using, you’re not gonna call it. It’s
against the Code”

(Participant 6, Age 37)

4.3.3 Availability of drugs
The Drugs Policy and Strategy (2006) of the Irish Prison Service strives for a drug-free
prison environment. The reality, though, is that drugs and alcohol are available in Irish
prisons. The availability of drugs in prison presents a constant difficulty to people who
are trying to achieve or maintain a drug-free existence. The effect on the prison
environment is that there is increased tension and the integrity of the drug treatment
programme is undermined, as this participant explains.
“If you are doing the drug treatment programme and if you have two people in
it who are getting drugs on their visits, that’s extremely difficult and then you
are going into meetings or groups and talking bullshit. You’re there and you
have to listen to that and you know they are using”.
(Participant 6, Age 37)
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4.3.4 Prison as an initiation into drug use
The prevalence of drugs in prison is one of the many challenges which the prison
environment presents to prisoners. While a high number of prisoners enter prison with
an addiction issue, there are some individuals for whom prison is where they are first
introduced to heroin. One reason for using drugs in prison is as a way to cope with the
prison environment.
“You’d have lads from the country being introduced to that (drugs). They
didn’t have a chance. Some of them would have taken heroin for the first time
when they were in prison. Could you blame them? They needed to survive.
They needed something to keep them sane and get them through the day”.
(Participant 5, Age 39).
4.3.5 Benefits of the Prison Environment and Drug Treatment
Having detailed the negative aspects of the prison environment, participants were able
to identify positive aspects of the prison environment. One participant demonstrated
how it was possible for him to become drug-free in prison. He also realized that it was
a significant achievement.
“The longest drug free time for me was 12 months. That’s a big deal when you
think about it, to be clean for a whole year.” (Participant 5, Age 39)
Certain areas in prison were considered to be more supportive of an individual engaged
in prison drug treatment. These areas within the prison environment deliberately
supported a drug-free life. One participant appreciated the increased contact he had
with family and the opportunity to study for a degree.
“I was at the stage where I wanted to get to ‘enhanced’. The conditions were
good there with more phonecalls, gym, teachers, extra visits … I did an Open
University degree at the time but not through Mountjoy.

I stayed on the

enhanced wing in St. Pats. I’d sleep there in Pats and then do my studies and
go back to St. Pats.” (Participant 5, Age 39)
One specific benefit of being in a drug-free environment is that it provided a space for
self-reflection.
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“It was time to think straight. I watched a lot of what was going on. Stuff I
was missing when I was using. But I learned a lot by watching.” (Participant 5,
Age 39)

4.4 Prison Drug Treatment
The second theme is prison drug treatment. It was a strong theme throughout all of the
interviews. This is not surprising due to the focus of the research. Participants raised
specific areas of prison drug treatment and commented on them from their perspective.
As participants were in prison at different times, between 1995 and 2015, there are
different views on prison drug treatment, depending on when the participant was in
prison. This difference in view is for the most part because of changes in prison drug
treatment between 1995 and 2015.

4.4.1 Person-centred treatment
One of the participants who had recent experience of prison between 2005 and 2015
felt that a person-centred approach to prison drug treatment was very important. In his
case, he felt unable to make informed decisions on his own treatment because of
inflexibility in the delivery of prison drug treatment and competing priorities within the
prison, such as security.
“It’s their way or no way. Treatment is way down the list of what’s important.
That’s just the way it is. Take it or leave it”. (Participant 3, Age 32)

4.4.2 Methadone
There was a strong reaction against methadone maintenance amongst some of the
participants. For them, methadone maintenance had a negative connotation and its use
was to be avoided. Methadone maintenance was perceived as ineffective in helping
the person to change and was an obstacle to recovery.
“I purposely didn’t want to be on methadone ‘cos I’ve seen what happens.
Yous get out the same way as you get in” (Participant 1, Age 37)

	
  

32	
  

Another participant viewed methadone maintenance as a life-long imposition and he
distanced himself from people who are on methadone maintenance.
“Methadone, yeah? No way pal and have me stuck on it forever. I see plenty of
those around. I’m not one of them. You go on that shit and you’re on it forever
mate. You never get off it”.

(Participant 3, Age 32)

4.4.3 Stigma
Even though drug and alcohol use is part of daily life in prison, stigmatization could
occur. One participant recalled a time when individuals who were publicly identified
in front of other prisoners as being involved in treatment were asked for information on
AA meetings.
“In the main jail it was hassle for the prison officers to come out to the yard … and
there was also a stigma ‘cos you were getting called in the yard out of 300
prisoners and asked if there’s an AA meeting on” (Participant 3, Age 32)
4.4.4 Staff
Medical staff were seen in a generally positive light, as mentioned by this individual.
“The medical staff are super. They detox you down 5 mils each time. I was
worried I wouldn’t sleep. So I got a sleeper too”. (Participant 2, Age 35)
However, some prison doctors were viewed as overly cautious and controlling. In the
medical context, the prisoner seemed at times to be a passive receiver of treatment
without much input into decision-making.

There was some awareness from this

participant of the dangers of detoxification.
“The prison doctor … is very cautious and very sceptical of people reducing off
methadone … they take a real kind of attitude to people when they come down
off it because they see the other side of it because when you come down off it
and use heroin there’s a chance you could relapse … it feels like control …
there’s always caution instead of encouragement … when people are trying to
come down off methadone” (Participant 7, Age 34)
For one participant, the confidentiality between doctor-patient was encroached upon
for reasons that seemed to be about curtailing drug supply.
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“You’d have a prison officer behind you when you’d meet a doctor and that
wasn’t good…If I met with a psychiatrist I’d have a private meeting but not
with the doctor…I guess it’s because you’d have lads looking for tablets.”
(Participant 5, Age 39)
This participant was able to recognise that the courtesy and respect between staff and
prisoners was a two-way process.
“I found the drug treatment programme and the Training Unit for me hugely
beneficial … I suppose the prison will work with you as long as you’re working
with them … If you are going in and calling prison officers scum bags and pigs,
they’re human beings, they’re not going to help you”. (Participant 6, Age 37)

4.4.5 Drug Treatment Programme
The Drug Treatment Programme, at times, was experienced as being somewhat
contrived. This participant explained how the selection seemed to be random and
lacking a thorough preparation. A more gradual preparation process would perhaps
have benefited his group.
“I would have got the sense it (prison drug treatment) was superficial. You
had eight people in on a landing and …. There’s no kind of going through the
process of change …. like, one day you are an addict in the main jail … where
… anything goes to going into therapy the next day with people you never met
before”. (Participant 6, Age 37)
The same participant continued his reflection on prison drug treatment by considering
the inter-personal dynamics of individuals in the group. These dynamics had an
impact which could help a group develop or prevent a group from functioning.
“If you get one or two bad eggs and they have an influence they can ruin it for
everybody. And as much as the other people might want it, you’re stuck with
that group of people. So that has a huge influence on how you do”. (Participant
6, Age 37)
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4.4.6 Fellowship Meetings
Fellowship Meetings were mentioned regularly by all interviewees as being very
important.
“I used alcoholics anonymous [AA], they came into the prison.”

(Participant

7, Age 34)
“The NA [Narcotics Anonymous] meetings were great. There was no other
place like them”.
(Participant 2, Age 35)
The consumption of alcohol was generally a seasonal occurrence, particularly at
Christmas time. However, it was explained that alcohol was consumed on a more
regular basis by foreign nationals. While Fellowship meetings were available, they
were times at times irregular.
“Alcohol … its more of a cultural thing. The foreign nationals take a lot of it
… but there were lads who had a drink problem … there were Fellowship
meetings like AA and NA so that would have helped. But they were in trends
and at time sporadic”. (Participant 5, Age 39)
When it was not possible to have a Fellowship meeting organized officially,
prisoners showed initiative and organized their own.
“There was no regular access by NA so we self-organised and arranged a time
and place every week” (Participant 5, Age 39)

4.4.7 Access
Access to prison drug treatment was experienced as difficult at times and seen as the
biggest issue for prison drug treatment. Lack of access was due to different reasons
but mainly because of the limited number of spaces.
“Now (2015) the biggest issue is getting access … there are only 9 places on it
… the prison population is 3400 … on average 70% will have addiction issues.
Do the sums on it per year …. that’s a total of 54 lads per year. But that’s if all
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goes well and they complete the course … it’s not big enough yet” (Participant
5, Age 39)
Access could also be hampered because the motivations of some participants were at
odds with what was required for prison drug treatment. This could have the collateral
effect of denying genuine participants access.
“The officers might not let you through … part of it is we were all tarred with
the same brush. You could have lads who were serious about getting clean and
then you’d have others who had a different plan … pass information, get at
someone.” (Participant 5, Age 39)

4.5 Communication
The third theme is communication. This theme arose from questions to participants
about how they got to know about prison drug treatment.

The responses from

participants suggested a communication gap between service providers and prisoners.
Participants describe different time periods between 1995 and 2015. An indication of
the period being referred to is included where available.

4.5.1 Lack of Communication
Participants indicated an overall lack of communication from prison authorities
regarding prison drug treatment. This resulted in a number of participants becoming
passive recipients of treatment, with very little active participation.
One participant recalled that, in 1995, there was no systematic screening process for
prison drug treatment. His experience of prison drug treatment was random and lacked
co-ordination.
“I would have just gone 18 (1995) … the Guards, em, just opened the door and
asked who was to see the doctor. That was it. That was the only question … I
got 50mils of brown methadone, having … only smoked heroin once at that
stage” (Participant 4, Age 38)
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Communication improved somewhat between 1998 and 2002. During this time, period
official communication regarding prison drug treatment was actively distributed
amongst the prison population.
“it (prison drug treatment) would have been advertised in the prison … I don’t
know what it’s like now but at the time they used put flyers around”
(Participant 6, Age 37)
Some communication issues were solved by prisoners sharing information with each
other through word of mouth.
“You heard about the meetings. It was somewhere to go. My first experience of
drug treatment was NA … I thought about me problems a lot” (Participant 2,
Age 35)
But, in general, those interviewed were unaware of supports.
“I wasn’t aware of any supports. When I was on remand I hadn’t a clue what
was available”. (Participant 5, Age 39)
4.5.2 Negative consequences
One danger resulting from the lack of communication was made evident by this
participant’s experience of going into withdrawals. His experience is from 2005.
“No I wasn’t told about treatment. Soon after I went ‘cold turkey’ … I was
shaky, puked for a day and a half, panic attacks. The rattle was bad. I was in
pieces after it. I got clean for 6 months until I was let out again. But then
you’re in and out again, you know, the revolving door … and it’s the same shit
all over again”. (Participant 3, Age 32)

4.5.3 Importance of Effective Communication
Participants in general were able to appreciate the multi-dimensional composition of
prison, with its many demands and pressures on resources. However, participants
expressed disappointment at not being informed by prison authorities about situations
which had a serious impact on them. One participant gave the example of finding it
difficult to access a doctor. In hindsight, the participant understands the complexity of
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healthcare in prison. However, he also explains that better communication would have
helped him understand why access to a doctor was difficult.
“At that time doctors were difficult to access … I understand now that it was
complex.

There was more to the picture than what I wanted.

I didn’t

understand then that detoxification could be dangerous and that doctors were
slow because of that … it might have helped if it was explained”. (Participant 5,
Age 39)

4.6 Change and the Impact of Policies on Prison Drug Treatment
The fourth theme is change and the impact of policies on prison drug treatment. Those
interviewed for this research project experienced prison in Ireland at different times
between 1995 and 2015. Throughout the interviews, there are indicators of change
over that time period which have shaped prison drug treatment. The general view of
prison drug treatment is that it has changed for the better but that this change is slow.
“My experience with prison services is they are trying … it’s just huge ... the
whole prison is” (Participant 6, Age 37)
4.6.1 Changes in Prison Drug Treatment
Participants

described

the

early

introduction

of

interventions,

including

detoxification in the 1990s.
“There was no maintenance in prisons at the time, no methadone maintenance
… everyone went in and got a six day detox” (Participant 6, Age 37)
Another participant shared his experience of the late 1990s and noted how significant it
was for the Irish Prison Service to acknowledge the scale of the drugs problem.
“I got a two week crash course of 87.5 mils of phy [physeptone]. Now this was
before the Medical Unit … so you’d do a detox over two weeks … It was a
massive step forward for the Irish Prison Service to acknowledge the drugs
problem. It was huge because up until then it was ‘turn a blind eye’ approach
to it”. (Participant 5, Age 39)
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Around 2000, the Irish Prison Service began the introduction of limited methadone
maintenance.
“My experience began in 1999. There was no real monitoring or criteria in
those first few years … but it was maybe late 2000 … that you’d notice things
beginning to shift.” (Participant 5, Age 39)
4.6.2 Impact of Policy
The 2006 Policy and Strategy on Drugs of the Irish Prison Service was mentioned by
one participant. From his responses, he views the Policy and Strategy, not as an
abstract document detached from reality, but rather as a document which impacts on
the lives of prisoners. He made an interesting point that, even though the focus of this
research is the perspectives of ex-prisoners, that there are other perspectives, in
particular, the political perspective, which cannot be ignored.
“In any of this you can’t forget the bigger picture … staff resistance … that’s
one perspective. Another perspective is what you are looking at. But there’s
the political perspective too and you can never ignore that because when
politics and prisons mix, the heavy hand falls”. (Participant 5, Age 39)
This participant was critical of the 2006 Policy and Strategy’s negative impact on
prisoners and in particular how it affected prison drug treatment. His comment is very
insightful and points out how geopolitics can affect prison drug treatment.
“The war on drugs … it’s not just in the US. It’s Europe, the UK and Ireland
as well … you see it in security – the barbed wire, the screens, the nets over
yards. That’s the Irish version of the American war on drugs. It aims to
prevent supply. It doesn’t look at what the needs are of a fella trying to get off
gear. The Strategy is the same. It’s a political document which is influenced
by the State and it’s more interested in the public opinion than what’s actually
the reality in prison”. (Participant 5, Age 39)
He summed up his perspective on the 2006 Strategy in the following quote:
“It hits the supply of drugs into prison but I don’t see how it helps prison drug
treatment.” (Participant 5, Age 39)
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4.6.3 Slow change
Changes in prison drug treatment have been definite but slow. A general comment on
the change in prison drug treatment was expressed which praised the Irish Prison
Service for change, even if the change is somewhat slow.
“The IPS [Irish Prison Service] have moved from the stone-age in the 90s. It’s
a big organization and some of it seems half-hearted and slow, but it is moving
and that’s something you have to give credit to. I know what it’s like and in
some ways things don’t have to change, but they have changed and continue to
change, it’s just that it goes so slowly.” (Participant 5, Age 39)
One participant was clear in his view that the slow-change and lack of funding
would not be acceptable for other institutions but that because it was prison, then
there was no political or public appetite to speed things up.
“If the Minister goes tomorrow and looks for a million euro for Crumlin
children’s hospital and somebody else goes looking for a million euro for
addiction services you can rest assure that the children will get it.”
(Participant 4, Age 38)
4.6.4 Role of leadership
The impact of specific personnel in leadership was mentioned as having a strong
influence on the direction and pace of change. The current Director General of the
Irish Prison Service was appointed in 2011.
“the new head of the prison service was the former head of Probation, Michael
Donnellan … he’s a big advocate for prisoners change, people changing in
prison, people getting out and starting their lives…he also brought single cells
back into Mountjoy…that was a big thing”

(Participant 7, Age 34)

This influence of leadership on change is further reflected in a more rehabilitative
approach to prison.
“Prison in Ireland is changing a bit now with the different people involved in
IPS. They are seeing a more rehabilitation side of approaching prison rather
than the corrective side … they seem to be putting more emphasis on

	
  

40	
  

rehabilitation and programmes now … they realize it’s a revolving door so they
have to stop it somehow”. (Participant 7, Age 34)

4.7 Attitude and Motivation
The fifth theme is attitude and motivation. This theme was mentioned as an essential
part of responding to prison drug treatment. The question put to participants was to do
with how prison drug treatment affected their life. The theme indicated how an
individual’s willingness to take responsibility for their own recovery played an
important role in prison drug treatment.
4.7.1 Desire to change
It was clear through each interview that all the participants had a desire for a life free
from chaotic drug using and free from the negative effects of substance misuse. The
supports in prison were appreciated as a necessary tool in achieving this.
“All I know is that without supports, fellas will keep going around in cycles and
that’s the same for the prison service too, just keep going around and round.”
(Participant 5, Age 39)
An improvement in the attitude of participants who engaged with prison drug treatment
helped in improving relations with prison staff. Although prison drug treatment could
be quite stressful for the participant, it was acknowledged as contributing to making
life easier in prison.

It was evident from the comments of participants that an

individual’s recovery was a hard-earned achievement.
“I became a model prisoner. I had only 2 or 3 reports. I learned to behave. I
got clean and good. But it was stressful, fuckin stress. The body has to
readjust”. (Participant 2, Age 35)
4.7.2 Honesty and Integrity
The importance of being genuine and honest in one’s attitude was seen as a positive
support in achieving treatment objectives. Individuals benefited from those around
them being genuine.
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“Stick with people that are kind of genuine…and who want to reach their goals
because that’s a huge part of it” (Participant 6, Age 37)
It was also important to be honest with oneself.
“It’s a whole lifestyle change…the cliché ‘people, places and things’ need to
change….you can’t lie to yourself” (Participant 6, Age 37)

4.7.3 Belief in Change
Belief for participants that positive change was possible in relation to substance misuse
often arose in the period leading up to the release date from prison. The impending
release date served as a motivation to change and prepare for life after prison.
“I was coming up to the two year mark before I’d get out and I said to myself
that I didn’t want to be the same person leaving prison as I was when I went it.
That was an important marker for me”. (Participant 5, Age 39)
While the shortage of prison drug treatment services would normally have had a
detrimental effect on individuals who did not secure a place, for one individual, it was
this shortage in services that moved him to change.
“The change for me came through myself. And it came through myself because
either the services were not there or the services that were there were
overwhelmed and unable to deal with all the people needing it”. (Participant 5,
Age 39)
4.7.4 Attitude towards prison drug treatment
When participants were asked what their general attitude was towards prison drug
treatment and whether they would recommend it, they expressed positive responses.
“Anything that’s positive in prison whether it be drug rehabilitation, education,
avail of it because they are the tools to change.”
(Participant 7, Age 34)
The importance of being proactive in one’s own recovery helped participants to utilise
the services available and also to reach out to particular individuals for support.
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“If you’re in Mountjoy and you’re serious…I would definitely encourage
following a programme…and it’s up to you to kind of advocate on your behalf
and get…Probation or a teacher in the school or someone to advocate on your
behalf. And at the end of the day you are the only one who will make that
change.” (Participant 7, Age 34)
Partnership between the individual and services ensured that both parties could achieve
their goals together. However, the active participation of the individual seeking prison
drug treatment is essential.
“If you are strong in your will and your conviction the services will come
around you; you won’t have to go looking for them because they’ll see it in you
that you want to change”. (Participant 7, Age 34)
One participant explained succinctly that the biggest obstacle for him in prison drug
treatment was his own internal struggle with addiction.
“(the biggest obstacle was) not wanting to let go of my addiction that I loved so
much”. (Participant 2, Age 35)
The general attitude and belief of participants towards prison drug treatment could be
summed up in the following quote:
“You don’t get anything in life on a plate. Prison drug treatment isn’t the
perfect package, but what is?

You’ve gotta keep at it til you get a

breakthrough. We’ve all been through times of not knowing where life is going
or what’s going on. Yeah, where we are in life, part of it can be blamed on
upbringing and not having enough of support and care as a child but the older
you get, you realize that you can make changes”. (Participant 5, Age 39)

4.8 Accountability
The sixth theme is accountability. The issue of accountability arose in each interview.
During the interview process, when participants mentioned an issue that they were
unhappy about, the interviewer asked if they had made a formal complaint. It was
generally accepted by participants that prisoners had very little influence over
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decisions made about them and that there was no satisfactory recourse to resolve their
complaints.
One reason given for not registering a complaint was because participants perceived
that it could adversely affect their chances of securing a place on a prison drug
treatment programme.
“Because of the shortage of space, you were in no bargaining position to be
complaining about anything in prison…So at the end of the day you couldn’t sit
there and bang the drum ‘well I want this and I want that’ because they’d just
tell you to fuck off”. (Participant 7, Age 34)
The securing of an appointment with a psychologist for this participant seemed to be
secured in an arbitrary fashion. Having been unsuccessful in his own attempt to secure
an appointment, after mentioning it informally to a teacher in the prison he was given
an appointment almost immediately.
“I was three years into my sentence but there was no psychologist available to
meet me…but there was a teacher and I mentioned what was going on for me in
passing, just in conversation, and then out of nowhere she got an appointment
for me for the next week”. (Participant 5, Age 39)
Some participants were left in a predicament because they were not accepted for
detoxification and neither could they sustain a regular drug habit because of the lack of
regular supply. This had serious effects on the participants including withdrawals.
“I was refused a detox … I couldn’t even lift a snooker cue (I was so weak) …
It was the worst experience in prison…caught between a rock and a hard place
– not on prison drug treatment and not getting regular supply.” (Participant 2,
Age 35)
The limited resources of prison drug treatment impacted on some participants who
wanted detoxification or a ‘taper’, but instead they were offered methadone
maintenance which they declined. The participants had a profound discomfort with the
methadone maintenance. This resulted in one participant going into withdrawals and
managing his own detoxification.
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“I didn’t want to go cold turkey but it was the only way or else go on
methadone. I was serious about getting clean and getting my head straight for
when I’d leave prison. So a taper would have been better, come off gear bit by
bit, in my own time.” (Participant 3, Age 32)
4.9 Conclusion
This chapter presented the main findings from the seven interviews conducted with
participants under the aims of this research. The six themes provide data for a
discussion on the findings, which will be the subject of the next chapter.
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CHAPTER FIVE: DISCUSSION
5.1 Introduction
This chapter discusses the main findings from the research conducted with the seven
participants.

From the review of literature, and the seven interviews which were

conducted, it is clear that prison drug treatment is a complex topic, with many
perspectives from which to view it. This chapter engages the literature review and the
findings from the interviews in a discussion so that, through the discussion, another
layer of understanding is established.

5.2 Profile of prisoners
The profile of prisoners in general is one of socio-demographic disadvantage. It is
clear from this study that this is the case internationally and in Ireland and also among
the seven participants. The experience of prison adds to that disadvantage in different
ways, which includes the lack of ‘equivalence of care’ in prison drug treatment.
Bauman (1998) is clear that prisons are deeply connected to the segregation of
unwanted groups through the process of ‘prizonisation’. While Cohen (2001) explains
the denial of Society around this knowledge, the reality is that prison drug treatment
cannot ignore the socio-economic and educational disadvantage of the prisoner profile.
The profile of prisoners highlights the potential that prisons have in helping people
recover from disadvantage.

Participants in this study identified how prison drug

treatment was an important support for them in their journey towards a life free from
chaotic drug use. An integrated understanding of all aspects of the individual’s life is
an essential feature of prison drug treatment and will note the importance of remedial
work in areas such as literacy, emotional development and employability.
5.3 Prison Environment
The impact of the prison environment is recognised throughout this study as being a
significant feature of prison drug treatment. Security is the over-arching influence on
all aspects of prison and prison drug treatment. The debate as to whether or not prison
is the correct environment for prison drug treatment raises deeper questions of the
relationship between drugs, crime and society, which are beyond the limits of this
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study. However, it is clear both from the literature and the interviews that prison adds
to the challenges of drug treatment. The negative aspects of the prison environment
are often easier to identify. These include boredom, violence, and the presence of
drugs. The presence of drugs can create a tense atmosphere and can also undermine
the integrity of therapy groups. In this study it was surprising to hear participants
identify the benefits of the prison environment. For some participants, their time in
prison was a time when they were drug-free for a significant period. This was a
considerable achievement. Drug-free wings contributed in a large way to providing a
supportive environment, indicating the strong influence the environmental setting can
have. Participants commented on how more content they were in drug-free wings
because of the supportive climate. While it a a drug-free environment would require an
increase in repressive measures without guaranteeing a reduction in supply, the
continued development of drug-free areas with aftercare is a realistic response to the
needs of individuals who are prepared to engage with prison drug treatment.

5.4 Healthcare
Prison drug treatment as a healthcare strategy has developed over the last thirty years.
The gap between what is available in the community and in the prison remains a
noticeable shortcoming. For as long as that gap persists, the human rights of prisoners
are infringed upon. While the difference between countries in Europe can hamper
comparisons, the move in some countries, towards giving responsibility for prison
healthcare to the structure which is responsible for the community, is an interesting
trend. It has the potential to improve healthcare and prison drug treatment, while also
moving closer to achieving ‘equivalence of care’. However, it has the potential to
deflect from other factors relevant to the individuals rehabilitation such as social,
behavioural and psychological needs. The medicalising of the needs of an individual
can result in compartmentalisation where there is the potential to avoid other needs
such as addressing socio-demographic disadvantage.
In addition to the move toward integrating prison and community healthcare on a
European level, a common instrument could assist in the measuring of effectiveness of
prison drug treatment. This would counteract the current situation where there is a
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variety of data collection and methodologies used which produces data which is
incomplete.
5.5 Delivery of prison drug treatment
What was surprising from the interviews with participants is that they made limited
critique of the control and sanctions within prison. They were not so concerned about
prison drug treatment itself but rather assessed their situation in prison, with reference
to their future and return to the community. While empirical research can go into a
deep analysis and examination of the content of drug treatment programmes, from the
perspective of ex-prisoners in this study what was of greater concern to them was the
manner in which treatment was actually delivered.

There was also a considered

understanding from participants towards the complexity involved in prison drug
treatment and the limitations on staff. This appreciation from participants indicates an
opportunity to strengthen relationships between staff and participants for the
development of services.

5.6 Attitude and Motivation
Another surprising revelation was to do with obstacles to prison drug treatment of
which there are many, such as access, availability of illicit drugs, and limited
resources. Participants, however, were frank in stating that the main obstacle to prison
drug treatment was the internal disposition of the participant. This degree of honesty,
self-reflection, and maturity of participants was a constant measure of their
engagement with this study.
What also emerged from this study is the challenge posed by limited resources in
prison drug treatment such as shortage of spaces.

While some participants were

creative in adapting to this through self-prescribed approaches to drug treatment, other
participants clearly suffered through unsupervised withdrawals. This raises the need
for on-going review and evaluation of prison drug treatment, which is already part of
the Irish Prison Drug Strategy (2006). What emerges through this study is the multiple
layers of challenges which participants had to deal with.

Although prison drug

treatment was a mixed experience for participants, they acknowledged that it was an
important service for them in helping them to become drug-free.
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5.7 Accountability
Accountability was a strong theme amongst all participants.

While there is a

complaints mechanism in the Irish Prison Service, participants did not believe that
there was any point in raising a complaint. Participants felt that their concern would
not be taken seriously, that there would be negative repercussions for them, and that it
was much easier to simply tolerate whatever was at issue. Accountability has been
acknowledged by academics as one of the most fundamental difficulties within the
Irish Prison Service. Accountability is an even more acute requirement, given the
closed nature of prisons, and the power differential between prisoners and staff. For
the legitimacy and integrity of prisons in general, and of the prison drug treatment in
particular, there needs to be a system of strong and independent oversight which has
the confidence of staff and in particular of prisoners.

5.8 Contribution of this study
What is clear from this study is that the number of participants is not large enough to
draw generalisations for the whole population who use prison drug treatment in
Ireland. It is not possible, therefore, to establish how representative these perspectives
are. In any case, while the perspective of ex-prisoners is not the definitive statement
on prison drug treatment, it offers an important insight into some experiences of prison
drug treatment.
The contribution made by this study is the perspectives of ex-prisoners on prison drug
treatment. It contributes important information to the literature of prison drug
treatment, such as the challenges for prison drug treatment, the delivery of services and
social relations. Through the perspectives of ex-prisoners, the researcher was able to
uncover experiences which gave insight into treatment modalities, attitudes, and the
prison environment.

The perspective of ex-prisoners also challenges assumptions

about what is involved in prison drug treatment.
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CHAPTER 6: CONCLUSION AND RECOMMENDATIONS
Prison drug treatment is a complex subject which has received a modest amount of
research, with less research still on user-perspectives. It is a topic which affects a
significant number of people in prisons across Europe. There are many perspectives
from which to explore prison drug treatment. The findings of this study arise from the
perspectives of ex-prisoners but cannot be applied in general across Irish prisons
because of the small sample. This study has looked at the European and Irish situation
with regard to prison drug treatment. It has highlighted the socio-demographic
background of prisoners, the environmental impact of the prison, the efficacy and
modality of prison drug treatment, prison drug treatment as a healthcare strategy,
accountability, and the need for regular review and evaluation. It has collected data
from seven participants who have experience of prison drug treatment in Ireland and,
from that, six themes developed. The discussion chapter has considered these themes,
along with the literature review, with a number of recommendations being made.
In light of the information of this study, the researcher makes the following
recommendations in relation to prison drug treatment in Ireland.
•

Develop research in the area of prison drug treatment in Ireland and, in
particular, from user-perspectives.

•

Ensure that there is ongoing monitoring, review and evaluation of prison drug
treatment by the Irish Prison Service.

•

Improve access to and ‘throughcare’ in prison drug treatment services.

•

Strengthen the structures for accountability within the Irish Prison Service.

•

Consider an integrated approach for prison drug treatment across Europe.

This study has countered in a small way the lack of user-perspectives on prison drug
treatment. The findings are enriched by interviews with seven participants who have
experience of prison drug treatment. Their insights were crucial in shaping this study.
Prison drug treatment in Ireland has developed slowly over the last twenty years. For
many different reasons though, it does not meet all of the needs of prisoners. The
researcher’s hope is that, in another twenty years, an exploratory study of ex-prisoners
perspectives on prison drug treatment will reveal an easier pathway to recovery.
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APPENDICES
Appendix 1: Consent Form
I have read this information sheet and have had time to consider whether to take part in this
study.
I understand that my participation is voluntary (it is my choice) and that I am free to withdraw
from the research at any time without disadvantage. I agree to take part in this research.
I understand that, as part of this research project I will be interviewed for a maximum period of
60 minutes on the topic of my experience of drug treatment in prison.
I understand that my name will not be identified and that it will be changed when the research
is written.
I am voluntarily agreeing to participate in this research.
I agree that the data can be used in the publication of higher degrees, scientific publications.
I understand that the completed research may appear online and in DIT library.

Name of Participant (in block letters):
______________________________________

Signature:_______________________________________________________

Date: / /
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Appendix 2: Information Letter
9th July 2015.
To the Director of Project X:
I am writing to you as a post-graduate student in Dublin Institute of Technology. I am
conducting research on the experience of ex-prisoners of drug treatment in prison.

The

research is for a Masters thesis in Criminology. It has received research ethics approval from
the Head of School of Languages, Law and Social Sciences, Dr. Kevin Lalor.
I have contacted you as Director of Project X, which is a drug-free community based education
programme in ________________.
My request is to interview six people individually about their perspective on drug treatment in
prison.

It would be one interview lasting a maximum of 60 minutes.

The research is

conducted in a confidential way with the exceptions to confidentiality if child protection
concerns arise.
The identity of each participant will be changed so as to provide anonymity. Data will be
securely stored throughout the research and then destroyed on completion of the study. The
use of a digital recorder with permission of the participant would be helpful but not essential.
Taking part in this research would be voluntary and consent can be withdrawn at any time.
The completed work may appear in the DIT library and online at www.arrow.dit.ie.
I am available by email on d13122683@mydit.ie for further information and questions. I can
also be contacted on

.

Yours sincerely,
Sean Duggan
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Appendix 3: Information Sheet

I am a student in Dublin Institute of Technology (DIT). I am carrying out research and need
your help.
The research project is on the views of people, with prison experience, about drug treatment
while in prison.
People who take part will be interviewed by me for a maximum period of 60 minutes.
I am interested in your experience, thoughts and opinions. What you say will be treated in
confidence. In other words, it will not be passed on to the Gardai or Prison authorities. The
one exception is if something arises which indicates that you are a danger to yourself or
someone else.
Your anonymity will be respected and your name will not be identified in any published
material.

Any notes, interview material or other data will be securely stored during the

research and then destroyed when the research is complete.
I would like to use a digital recorder during the interview if possible. This is so that I can get
everything that is said and not need to take notes. If you would prefer that the interview not be
recorded, I can take notes instead.
Taking part in this research is completely voluntary. You have the right and the choice to
withdraw at any time. There will be no penalty for withdrawing and your access to services
will not be affected.
One risk in taking part in this research is that it could raise some upsetting memories for you.
One benefit in taking part is that you will be making an important contribution to the
knowledge and understanding of drug treatment in prison.
I can be contacted by email on d13122683@mydit.ie
If you would like to talk to my Supervisor for more details, please contact Dr. Kevin Lalor by
email on kevin.lalor@dit.ie
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